Pharma market rebounds, asthma drug top seller
India's pharmaceutical retail market rebounded in November with double-digit growth, driven by increased demand for dermatological and cardiac medications. Respiratory issues, exacerbated by pollution, boosted Foracort sales to Rs 82 crore. Both acute and chronic medications saw 11% growth, and industry volumes rose by 3.5%. Analysts predict continued growth in 2025, fueled by price increases and new drug launches.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
